scholarly journals Clinical application of totally implantable venous access ports in patients with breast cancer

2020 ◽  
Author(s):  
Peng Zhang ◽  
Xueli Mo ◽  
Jun Du ◽  
Changsheng Fan ◽  
Jie Dong ◽  
...  

Abstract Background Totally implantable venous access port (TIVAP) has become an effective approach for venous access chemotherapy in cancer treatment. We aimed to show the important procedures of clinical application of TIVAP and complications management in breast cancer.Patients and Methods From January 2013 to December 2017, patients with breast cancer who took TIVAP operation were investigated. The key procedures of TIVAP conduct and its complications were evaluated in this study.Results One hundred and ten ports were applied to 110 patients with breast cancer. All ports were successfully implanted in all patients including 108 male and 2 male patients. Patients were followed for an average of 275 days. Conclusion It is safe and effective of TIVAP implantation by blind puncture applied in patients with breast cancer. Chemotherapeutic drugs delivery on the placement day seems safe and showed no more complications.

2021 ◽  
Vol 27 ◽  
Author(s):  
Kuo Chen ◽  
Narasimha M. Beeraka ◽  
Yuanting Gu ◽  
Jingruo Li ◽  
Mikhail Sinelnikov ◽  
...  

Background: Totally implantable venous access port system (TIVAPS) is widely used in breast cancer therapy; TIVAPS has several associated complications depending on the depth of implantation in breast cancer (BC) patients during continuous infusional chemotherapy regimens. The purpose of this study is to find out the optimal depth of TIVAPS implantation to reduce the incidence of complications during infusional chemotherapy. Methods: This study reviewed the depth TIVAPS implantation in the internal jugular vein in 1282 breast cancer patients over a ten-year period (2009-2019), and associated complications. We segregated the patients as 5 groups: ‘Group A (depth < 4 mm), Group B (depth of 4-8 mm), Group C (depth of 8-12 mm), and Group D (depth of 12-16 mm), and Group E (depth of > 16 mm)’. Consequently, the ‘internal complications’ such as infection, venous thrombotic syndrome, catheter folding & migration, extravasation, whereas the ‘external complications’ viz., inflammation, local hematoma, local cutaneous reactions, and port exteriorization were significantly analyzed during TIVAPS implantation at different depths in BC patients. Results: Overall incidence of ‘internal complications’ such as infections, venous thrombotic syndrome, catheter folding & migration, and extravasation was comparatively lesser in Group C (8-12 mm) than Group A, Group B, Group D, and Group E, respectively. Mainly, the external complications such as inflammation Group C (8-12 mm) (p<0.01) were lesser (6.8%, 3/44 cases) than Group A, Group B, Group D, Group E. On a similar note, the local hematoma, and local cutaneous reaction, and port exteriorization were observed as ‘5% (1/20 cases), 4.2% (2/47 cases), and (3.2%, 1/31 cases)’ in Group C patients (p<0.01), which were comparatively lesser than the other groups. Conclusion: Subcutaneous implantation of TIVAPS at a depth of 8-12 mm could be preferred due to the lowest incidence of internal and external complications compared to the incidence of these complications in other groups; this depth could be referred to as the safe and convenient implantation depth for the effective delivery of chemotherapy regimen in BC patients without difficulty in transcutaneous access to the port.


2015 ◽  
Vol 16 (4) ◽  
pp. 315-320 ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Eun Young Kang ◽  
Hwan Seok Yong ◽  
Jae Hong Seo ◽  
...  

Author(s):  
Petros Fountoulakis ◽  
Aikaterini Siama ◽  
Aimilianos Kalogeris ◽  
Marianthi Iliopoulou ◽  
Athanasios Tsoukas ◽  
...  

Fungal endocarditis, a rare and lethal infection, is aetiologically connected with Candida and Aspergillus species. Among these two agents, Candida is a common nosocomial infection with increasing rates over the last years and mortality up to 40% in cases of systemic candidiasis. In the present paper, we describe the case of a 58 year old woman with metastatic breast cancer under palliative chemotherapy who was hospitalized for recurrent episodes of fever due to fungal endocarditis of the implantable venous access port. Such cases may elude the attention of the physician and need to be taken into account especially in oncologic patients with implantable devices under chemotherapy regimens. The treatment of Candida endocarditis can be difficult because of the formation of biofilms on prosthetic devices. The prognosis of these patients may be ameliorated with the combination of fungal and invasive treatment.


2018 ◽  
Vol 19 (6) ◽  
pp. 615-619 ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Yun Hwan Kim ◽  
Sung Bum Cho ◽  
Hwan Hoon Chung ◽  
...  

The effect of catheter diameter on left innominate vein stenosis in breast cancer patients after totally implantable venous access port placement. Purpose: To evaluate the effect of catheter diameter on left innominate vein stenosis in breast cancer patients after placement of totally implantable venous access ports. Materials and methods: Totally implantable venous access ports were placed via the left internal jugular vein in 241 women with right breast cancer from January 2010 to December 2014 (mean age, 51.5 years; range, 19–83 years). There were 67 totally implantable venous access ports with a 6.5F catheter and 142 totally implantable venous access ports with an 8F catheter. Medical records were retrospectively reviewed. The presence of significant left innominate vein stenosis and tip location of the catheter was evaluated on chest computed tomography images. Statistical analysis was performed. Results: Left innominate vein stenosis developed in 1 (1.5%) and 13 (9.2%) patients after implantation with 6.5 and 8F catheters, respectively. Difference in the cumulative incidence of left innominate vein stenosis was statistically significant between the two groups (log rank test p-value: 0.002). In Cox regression analysis, the hazard ratio for left innominate vein stenosis was 20.766 ( p = 0.005) for an 8F catheter. Conclusion: The incidence of left innominate vein stenosis was higher after implantation of totally implantable venous access ports with 8F catheter rather than with 6.5F catheter. Considering that using 8F catheter versus 6.5F catheter has no advantage in terms of performance of the device, the results of our study suggest that ports with catheters >7F should be avoided.


Sign in / Sign up

Export Citation Format

Share Document